Skip to ContentSkip to MenuSkip to Footer
Back to Press Releases
April 18, 2025

TheraNovex Introduces Comprehensive IRB Checklist Tool

Streamlined submission process reduces IRB review time by 40% and ensures 100% compliance with regulatory requirements

TheraNovex today announced the launch of its comprehensive IRB Checklist Tool, designed to streamline Institutional Review Board submissions and ensure complete regulatory compliance. The platform features automated validation, progress tracking, and collaborative review capabilities, reducing submission preparation time by 60% while maintaining 100% compliance standards.

Key Features

  • Automated compliance validation and verification
  • Comprehensive document management system
  • Collaborative review and approval workflows
  • Real-time compliance monitoring and alerts

Performance Metrics

40%
Faster Reviews
60%
Time Savings

Simplifying IRB Submissions

Preparing submissions for Institutional Review Boards has traditionally been a complex, time-consuming process fraught with potential for errors and delays. The TheraNovex IRB Checklist Tool transforms this critical step in clinical research by providing a systematic, guided approach that ensures nothing is overlooked.

"IRB approval is a crucial gateway for clinical research, but the submission process shouldn't be a barrier to important medical advances," said Dr. Sarah Williams, VP of Regulatory Affairs at TheraNovex. "Our IRB Checklist Tool empowers research teams to prepare complete, compliant submissions efficiently, allowing them to focus on their groundbreaking research."

Comprehensive Compliance Framework

The IRB Checklist Tool provides exhaustive coverage of all regulatory requirements:

  • Protocol documentation and version control
  • Informed consent form validation and optimization
  • Principal investigator qualifications verification
  • Site documentation and facility assessments
  • Risk assessment and mitigation strategies
  • Data management and privacy compliance
  • Adverse event reporting procedures
"The IRB Checklist Tool has revolutionized our submission process. What used to take weeks of preparation now takes days, and we have complete confidence in our compliance."
— Dr. Jennifer Park, Principal Investigator, University Medical Center

Automated Validation and Quality Assurance

The platform's intelligent validation system automatically checks submissions against regulatory requirements, identifying potential issues before they reach the IRB. This proactive approach significantly reduces the likelihood of requests for additional information or resubmissions.

100%
Compliance validation accuracy
85%
Reduction in resubmissions
40%
Faster IRB review times

Collaborative Review Workflows

The IRB Checklist Tool supports multi-user collaboration, allowing research teams to work together seamlessly on submission preparation. Role-based access controls ensure that team members can contribute to their areas of expertise while maintaining document integrity and security.

Integration and Scalability

Designed to integrate with existing research management systems, the IRB Checklist Tool scales from single-site studies to complex multi-center trials. The platform maintains consistent quality and compliance standards regardless of study size or complexity.

"We built this tool based on years of experience working with research teams who struggled with IRB submission complexity," added Michael Chen, Product Director at TheraNovex. "By systematizing and automating the process, we're helping researchers get their important work approved faster and with greater confidence."

About TheraNovex

TheraNovex is a leading clinical research technology company dedicated to accelerating medical breakthroughs through innovative solutions. Our comprehensive platform suite includes regulatory compliance tools, submission management, and research optimization solutions, all designed to make clinical trials more efficient and compliant.

For more information about TheraNovex's IRB Checklist Tool, visit www.theranovex.com or contact our regulatory team at regulatory@theranovex.com.

All Press Releases
Published April 18, 2025